Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna greaves brewster llp
no operation time available
1 office
active in Legal Services

David Richard Spinner has worked on the following 45 EPO patent applications which have been published in the last five years:

EP12720055

METHODS OF TREATING SQUAMOUS CELL CARCINOMA RELATED APPLICATIONS

IPC classification:
G01N 33/574
Applicant:
Novartis AG
Agent:
David Richard Spinner, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12836762

SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA

IPC classification:
C12Q 1/48
Agent:
Philippe Ahner, Brevalex
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12720757

METHOD OF TREATING VISION DISORDERS

IPC classification:
A61P 27/02, C07K 16/22
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11711322

COMPOSITION COMPRISING THE AMYLOID BETA 1-6 PEPTIDE COUPLED TO A VIRUS-LIKE PARTICLE AND AN ADJUVANT

IPC classification:
A61K 39/00, A61K 47/48, A61P 25/28
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13760262

DEVICE FOR MANUFACTURING POLYMER FIBERS AND USES THEREOF

IPC classification:
A61L 33/06, B29C 47/00, D01D 5/30, D01D 5/38
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13777952

METHOD OF TREATING AN OCULAR DISEASE AND COMPOSITIONS EFFECTIVE FOR TREATING AN OCULAR DISEASE

IPC classification:
A61K 38/13
Applicant:
Howard University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP13798068

SELECTIVE BINDING OF BIOLOGICAL TARGETS TO SOLID PHASE UREIDES

IPC classification:
B01D 15/00, C12N 7/02, G01N 33/48
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13796498

MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS FIELD

IPC classification:
B01D 15/36, B01D 15/38, B01D 39/00, C07C 55/02, C07C 55/22, C07C 211/14, C07C 233/47, C07C 259/06, C07K 1/18
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13810714

RECONSTITUTION DEVICE

IPC classification:
A61M 5/28, A61M 5/315
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13810751

INDUCTION OF ESTROGEN RECEPTOR BETA BY CHOLESTEROL BIOSYNTHESIS INHIBITORS AND METHODS OF TREATMENT OF CANCER

IPC classification:
A61K 31/56, A61K 31/5685, A61P 35/00
Applicant:
The Curators Of The University Of Missouri
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP13813988

ANTIBODIES TO TAU

IPC classification:
C07K 16/18, G01N 33/53
Applicant:
Washington University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13762842

SALMONID ALPHAVIRUS AND USES THEREOF

IPC classification:
A61K 39/12, C07K 14/18, G01N 33/569
Applicant:
Novartis Tiergesundheit AG
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
PATENT GRANTED
EP13839678

GROUPING FOR CLASSIFYING GASTRIC CANCER

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
National University of Singapore
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13789453

FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

IPC classification:
C07K 14/005, C12Q 1/68
Applicant:
Cornell University
Applicant:
Novartis Tiergesundheit AG
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP13859964

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
A61K 45/00
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP15163041

CELL LINE AND METHODS FOR IMPROVED GLYCOPROTEIN SIALYLATION

IPC classification:
C12N 9/24, C12N 15/113, C12P 21/04, C12P 21/06
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP14751487

A POLYMERIC SYSTEM FOR RELEASE OF AN ACTIVE AGENT

IPC classification:
A61K 47/30, A61K 47/48, A61L 27/44, A61L 27/50
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP14726176

INTERACTIONS OF BETANODAVIRUSES IN INFECTION

IPC classification:
A61K 39/12
Applicant:
University of Málaga (Universidad de Malaga)
Applicant:
Novartis Tiergesundheit AG
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14748051

METHODS FOR PREPARING INACTIVATED ROTAVIRUS

IPC classification:
A61K 39/12, C12N 7/00
Applicant:
Novartis Tiergesundheit AG
Agent:
David Richard Spinner, Greaves Brewster LLP
Agent:
Sean Matthew Alexander, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP15202325

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME

IPC classification:
C12N 15/82
Applicant:
BASF Plant Science Company GmbH
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP13151551

Compositions and methods for use for antibodies against sclerostin

IPC classification:
A61K 31/663, A61K 39/00, A61K 39/395, A61K 45/06, C07K 16/18, C12N 15/13, C12N 15/63, G01N 33/68
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP14843476

SYNTHETIC POLYMERIC MATERIALS AND DEVICES THEREOF

IPC classification:
C08G 63/91, C08G 77/20, C08L 43/04
Applicant:
Colorado State University Research Foundation
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14846178

SEMI-AUTOMATIC SPHYGMOMANOMETER SYSTEM

IPC classification:
A61B 5/0225
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14845825

IMMUNOASSAYS USING OVER-LABELED FLUORESCENT PROBES

IPC classification:
G01N 33/53
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP11716204

METHODS AND COMPOSITIONS FOR IMPROVING IMPLANT OSSEOINTEGRATION

IPC classification:
A61K 9/00, A61K 31/675, A61K 39/395, A61K 45/06, A61L 27/28, A61L 27/32, A61L 27/34, A61L 27/54, A61P 41/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14856488

INTRA-AMNIOTIC ADMINISTRATION OF PROTEINS FOR THE TREATMENT OF ECTODERMAL DYSPLASIAS

IPC classification:
A61K 38/00, A61K 39/00
Applicant:
University of Erlangen-Nürnberg (Friedrich-Alexander-Universität Erlangen-Nürnberg)
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16155761

METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE

IPC classification:
A61K 38/19, A61K 38/21, A61P 25/00, A61P 25/28, A61P 37/00, C07K 14/535
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11761888

MACROCYCLIC LACTONE RESISTANCE MARKER FOR DIROFILARIA IMMITIS

IPC classification:
C07H 21/04, C07K 14/435, C12N 15/12, C12Q 1/68
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16158001

METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOOD

IPC classification:
A61B 5/00, G01N 33/48, G01N 33/68
Applicant:
Washington University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP14872184

MICRO RNA ISOLATION FROM BIOLOGICAL FLUID

IPC classification:
C07H 21/04, C12Q 1/68, G01N 33/53, G01N 33/566
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP14830849

BIOMARKERS AND METHODS RELATING TO ALZHEIMER'S DISEASE

IPC classification:
G01N 33/68
Applicant:
King's College London
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15701433

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF AMINO ACIDS IN HYDROGENOTROPHIC MICROORGANISMS

IPC classification:
C12R 1/01
Agent:
Anna Louise Gregson, Mathys & Squire LLP
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15748750

ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/167
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15782530

INTEGRATED CELLULOSIC ETHANOL PRODUCTION PROCESS

IPC classification:
C12N 1/16, C12P 7/06, C12P 7/10, A23L 29/30, A23L 29/212, A23L 7/104
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183719

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP16183725

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP15786641

EPIGENETIC MODIFICATION OF MAMMALIAN GENOMES USING TARGETED ENDONUCLEASES

IPC classification:
C12Q 1/02, C12Q 1/68
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183724

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183717

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP15746604

PROCESS FOR THE PREPARATION OF A C5-ENRICHED JUICE STREAM

IPC classification:
C08B 30/00
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183723

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183720

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP16195608

TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES

IPC classification:
A61K 38/21, A61P 35/00, C07K 16/32, C12N 15/62
Applicant:
The Regents of the University of California
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15734489

BOTTOM LOADED PEDICLE SCREW

IPC classification:
A61B 17/70
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15842126

ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS

IPC classification:
A01N 43/50, A01P 1/00, A61K 31/4178, A61P 31/00, C07D 233/56
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made

Please Sign in to use this feature